What should we advise MAFLD patients to eat and drink?

Abstract

In a time of food abundance and waste, and when sedentarism is the norm, metabolic-associated fatty liver disease (MAFLD) has become a major health threat in the Western world. While research is committed to finding a pharmacological treatment for MAFLD, it is time to go back to the basis and address the behavioral pathogenesis of MAFLD. All patients with MAFLD, irrespective of body weight, should be submitted to thorough dietary counseling. Diet is a learned behavior and should be addressed holistically and in a personalized fashion. The benefits of a suitable diet surpass an improvement of liver disease, having the potential to improve cardiovascular- and cancer-related mortality, in patients with MAFLD. This review summarizes the current state of the art of diet on MAFLD, presenting straightforward recommendations for everyday practice.

Keywords

MAFLD / diet / recommendations

References

[1] Jew S,Jones PJ.Evolution of the human diet: linking our ancestral diet to modern functional foods as a means of chronic disease prevention.J Med Food2009;12:925-34

[2] Younossi ZM,Younossi Y.Epidemiology of chronic liver diseases in the USA in the past three decades.Gut2020;69:564-8

[3] Goldberg D,Saeian K.Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation.Gastroenterology2017;152:1090-9.e1 PMCID:PMC5367965

[4] Noureddin M,Bresee C.NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances.Am J Gastroenterol2018;113:1649-59

[5] Kim D,Sandhu KK,Cheung AC.Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States.J Hepatol2021;

[6] Eslam M,Sarin SK.A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement.J Hepatol2020;73:202-9

[7] Neuschwander-Tetri BA.Therapeutic landscape for NAFLD in 2020.Gastroenterology2020;158:1984-98.e3

[8] Romero-Gómez M,Trenell M.Treatment of NAFLD with diet, physical activity and exercise.J Hepatol2017;67:829-46

[9] Cizza G.Was Feuerbach right: are we what we eat?.J Clin Invest2011;121:2969-71 PMCID:PMC3148750

[10] Musso G,De Michieli F.Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis.Hepatology2003;37:909-16

[11] Cortez-Pinto H,Barros H,Moura MC.How different is the dietary pattern in non-alcoholic steatohepatitis patients?.Clin Nutr2006;25:816-23

[12] Zelber-Sagi S,Goldsmith R.Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study.J Hepatol2007;47:711-7

[13] Jia Q,Zhang Q.Dietary patterns are associated with prevalence of fatty liver disease in adults.Eur J Clin Nutr2015;69:914-21

[14] Wehmeyer MH,Jagemann B.Nonalcoholic fatty liver disease is associated with excessive calorie intake rather than a distinctive dietary pattern.Medicine (Baltimore)2016;95:e3887 PMCID:PMC4907683

[15] Cheng Y,Chen Y.Associations between dietary nutrient intakes and hepatic lipid contents in NAFLD patients quantified by ¹H-MRS and dual-echo MRI.Nutrients2016;8:527 PMCID:PMC5037514

[16] Rietman A,Feskens EJM,Mensink M.Associations between dietary factors and markers of NAFLD in a general Dutch adult population.Eur J Clin Nutr2018;72:117-23

[17] Alferink LJ,Erler NS.Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study.Gut2019;68:1088-98

[18] Noureddin M,Wilkens LR.Diet associations with nonalcoholic fatty liver disease in an ethnically diverse population: the multiethnic cohort.Hepatology2020;71:1940-52 PMCID:PMC7093243

[19] Heilbronn LK,Campbell LV.The effect of short-term overfeeding on serum lipids in healthy humans.Obesity (Silver Spring)2013;21:E649-59

[20] Sevastianova K,Kotronen A.Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans.Am J Clin Nutr2012;96:727-34

[21] Sobrecases H,Bortolotti M.Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men.Diabetes Metab2010;36:244-6

[22] Haufe S,Kast P.Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects.Hepatology2011;53:1504-14

[23] Sacks FM,Carey VJ.Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates.N Engl J Med2009;360:859-73 PMCID:PMC2763382

[24] Kirk E,Finck BN,Patterson BW.Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction.Gastroenterology2009;136:1552-60 PMCID:PMC2677125

[25] Koopman KE,Nederveen AJ.Hypercaloric diets with increased meal frequency, but not meal size, increase intrahepatic triglycerides: a randomized controlled trial.Hepatology2014;60:545-53

[26] Takahashi F,Kawano R.Eating fast is associated with nonalcoholic fatty liver disease in men but not in women with type 2 diabetes: a cross-sectional study.Nutrients2020;12:2174

[27] Lee S,Gong Y.Self-reported eating speed in relation to non-alcoholic fatty liver disease in adults.Eur J Nutr2016;55:327-33

[28] Lê KA,Stettler R.A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans.Am J Clin Nutr2006;84:1374-9

[29] Silbernagel G,Unmuth S.Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial.Br J Nutr2011;106:79-86

[30] Sock ET, Lê KA, Ith M, Kreis R, Boesch C, Tappy L. Effects of a short-term overfeeding with fructose or glucose in healthy young males.Br J Nutr2010;103:939-43

[31] Chung M,Patel K,Lau J.Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis.Am J Clin Nutr2014;100:833-49 PMCID:PMC4135494

[32] Johnston RD,Crossland H.No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men.Gastroenterology2013;145:1016-25.e2

[33] Schwarz JM,Wen MJ.Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat.J Clin Endocrinol Metab2015;100:2434-42 PMCID:PMC4454806

[34] Stanhope KL,Keim NL.Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.J Clin Invest2009;119:1322-34 PMCID:PMC2673878

[35] Geidl-Flueck B,Németh Á.Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: a randomized controlled trial.J Hepatol2021;75:46-54

[36] Donnelly KL,Schwarzenberg SJ,Boldt MD.Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.J Clin Invest2005;115:1343-51 PMCID:PMC1087172

[37] Neuschwander-Tetri BA.Carbohydrate intake and nonalcoholic fatty liver disease.Curr Opin Clin Nutr Metab Care2013;16:446-52

[38] Ren LP,Zeng XY.Differing endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance.PLoS One2012;7:e30816 PMCID:PMC3280252

[39] Cox CL,Schwarz JM.Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women.Eur J Clin Nutr2012;66:201-8 PMCID:PMC3252467

[40] Bortolotti M,Schneiter P.Effects of dietary protein on lipid metabolism in high fructose fed humans.Clin Nutr2012;31:238-45

[41] Matsuzaka T,Yahagi N.Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice.Diabetes2004;53:560-9

[42] Hannou SA,McKeown NM.Fructose metabolism and metabolic disease.J Clin Invest2018;128:545-55 PMCID:PMC5785258

[43] Johnson RJ,Sautin YY.Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?.Endocr Rev2009;30:96-116 PMCID:PMC2647706

[44] Abdelmalek MF,Horska A.Fatty Liver Subgroup of Look AHEAD Research GroupHigher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes.Hepatology2012;56:952-60 PMCID:PMC3406258

[45] Nakagawa T,Zharikov S.A causal role for uric acid in fructose-induced metabolic syndrome.Am J Physiol Renal Physiol2006;290:F625-31

[46] Ackerman Z,Grozovski M.Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction.Hypertension2005;45:1012-8

[47] Perez-Pozo SE,Nakagawa T,Johnson RJ.Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response.Int J Obes (Lond)2010;34:454-61

[48] Spruss A.Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease.J Nutr Biochem2009;20:657-62

[49] Ullah R,Nabi G.Role of nutrition in the pathogenesis and prevention of non-alcoholic fatty liver disease: recent updates.Int J Biol Sci2019;15:265-76 PMCID:PMC6367556

[50] Ouyang X,Sautin Y.Fructose consumption as a risk factor for non-alcoholic fatty liver disease.J Hepatol2008;48:993-9 PMCID:PMC2423467

[51] Abdelmalek MF,Guy C.Nonalcoholic Steatohepatitis Clinical Research NetworkIncreased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease.Hepatology2010;51:1961-71 PMCID:PMC2922495

[52] Sievenpiper JL,Chatha S.Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: systematic review and meta-analysis of experimental trials in humans.Diabetes Care2009;32:1930-7 PMCID:PMC2752906

[53] Livesey G.Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies.Am J Clin Nutr2008;88:1419-37

[54] Fakhoury-Sayegh N,Sayegh R.Fructose threshold for inducing organ damage in a rat model of nonalcoholic fatty liver disease.Nutr Res2019;62:101-12

[55] DiStefano JK.Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis.Cell Mol Life Sci2020;77:2079-90 PMCID:PMC7440926

[56] Jin C,Li C.The sugar and energy in non-carbonated sugar-sweetened beverages: a cross-sectional study.BMC Public Health2019;19:1141 PMCID:PMC6700807

[57] Malik VS.Sugar-sweetened beverages and cardiometabolic health: an update of the evidence.Nutrients2019;11:1840 PMCID:PMC6723421

[58] Maersk M,Stødkilde-Jørgensen H.Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study.Am J Clin Nutr2012;95:283-9

[59] Mattei J,Hu FB.Substituting homemade fruit juice for sugar-sweetened beverages is associated with lower odds of metabolic syndrome among Hispanic adults.J Nutr2012;142:1081-7 PMCID:PMC3349979

[60] Odegaard AO,Czerwinski SA,Demerath EW.Sugar-sweetened and diet beverages in relation to visceral adipose tissue.Obesity (Silver Spring)2012;20:689-91 PMCID:PMC3288354

[61] Ma J,Fox CS.Sugar-sweetened beverage consumption is associated with abdominal fat partitioning in healthy adults.J Nutr2014;144:1283-90 PMCID:PMC4093984

[62] Ma J,Hwang SJ,Jacques PF.Sugar-sweetened beverage consumption is associated with change of visceral adipose tissue over 6 years of follow-up.Circulation2016;133:370-7 PMCID:PMC4729662

[63] Bray GA.Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes?.Diabetes Care2014;37:950-6

[64] Aeberli I,Hochuli M.Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial.Am J Clin Nutr2011;94:479-85

[65] Schulze MB,Ludwig DS.Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women.JAMA2004;292:927-34

[66] Pan A,Schulze MB,Willett WC.Plain-water intake and risk of type 2 diabetes in young and middle-aged women.Am J Clin Nutr2012;95:1454-60 PMCID:PMC3349456

[67] Siegel KR,Ali MK,Narayan KM.Societal correlates of diabetes prevalence: an analysis across 94 countries.Diabetes Res Clin Pract2012;96:76-83

[68] Koning L, Malik VS, Kellogg MD, Rimm EB, Willett WC, Hu FB. Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men.Circulation2012;125:1735-41, S1 PMCID:PMC3368965

[69] Zhang YB,Chen JX,Pan A.Association of consumption of sugar-sweetened beverages or artificially sweetened beverages with mortality: a systematic review and dose-response meta-analysis of prospective cohort studies.Adv Nutr2021;12:374-83 PMCID:PMC8009739

[70] Assy N,Kamayse I.Soft drink consumption linked with fatty liver in the absence of traditional risk factors.Can J Gastroenterol2008;22:811-6 PMCID:PMC2661299

[71] Abid A,Nseir W,Grosovski M.Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome.J Hepatol2009;51:918-24

[72] Meng G,Yu F.Soft drinks consumption is associated with nonalcoholic fatty liver disease independent of metabolic syndrome in Chinese population.Eur J Nutr2018;57:2113-21

[73] Stepien M,Fedirko V.Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort.Eur J Nutr2016;55:7-20 PMCID:PMC6284800

[74] Li Y,He K,Tang S.Consumption of sugar-sweetened beverages and fruit juice and human cancer: a systematic review and dose-response meta-analysis of observational studies.J Cancer2021;12:3077-88 PMCID:PMC8040874

[75] Ruanpeng D,Cheungpasitporn W.Sugar and artificially sweetened beverages linked to obesity: a systematic review and meta-analysis.QJM2017;110:513-20

[76] Drouin-Chartier JP,Li Y.Changes in consumption of sugary beverages and artificially sweetened beverages and subsequent risk of type 2 diabetes: results from three large prospective U.S. cohorts of women and men.Diabetes Care2019;42:2181-9 PMCID:PMC6868459

[77] Hirahatake KM,Shikany JM.Cumulative intake of artificially sweetened and sugar-sweetened beverages and risk of incident type 2 diabetes in young adults: the Coronary Artery Risk Development In Young Adults (CARDIA) Study.Am J Clin Nutr2019;110:733-41 PMCID:PMC6736196

[78] Muraki I,Manson JE.Fruit consumption and risk of type 2 diabetes: results from three prospective longitudinal cohort studies.BMJ2013;347:f5001 PMCID:PMC3978819

[79] Jenkins DJ,Kendall CW.The relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes.Diabetologia2011;54:271-9 PMCID:PMC3017317

[80] Vaisman N,Izkhakov Y.Catalytic amounts of fructose may improve glucose tolerance in subjects with uncontrolled non-insulin-dependent diabetes.Clin Nutr2006;25:617-21

[81] Moore MC,Mann SL.Acute fructose administration improves oral glucose tolerance in adults with type 2 diabetes.Diabetes Care2001;24:1882-7

[82] Pepino MY.Metabolic effects of non-nutritive sweeteners.Physiol Behav2015;152:450-5 PMCID:PMC4661066

[83] Suez J,Zeevi D.Artificial sweeteners induce glucose intolerance by altering the gut microbiota.Nature2014;514:181-6

[84] Ma J,Jacques PF.Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts.J Hepatol2015;63:462-9 PMCID:PMC4827616

[85] Malik VS,Pan A.Long-term consumption of sugar-sweetened and artificially sweetened beverages and risk of mortality in US adults.Circulation2019;139:2113-25 PMCID:PMC6488380

[86] Anderson JJ,Welsh P.The associations of sugar-sweetened, artificially sweetened and naturally sweet juices with all-cause mortality in 198,285 UK Biobank participants: a prospective cohort study.BMC Med2020;18:97 PMCID:PMC7181499

[87] Ahmadi S,Nagpal R.Dietary polysaccharides in the amelioration of gut microbiome dysbiosis and metabolic diseases.Obes Control Ther2017;4:10.15226/2374-8354/4/2/00140 PMCID:PMC6249025

[88] Esposito K,Ciotola M.Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial.JAMA2004;292:1440-6

[89] Lindström J,Eriksson JG.High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the Finnish diabetes prevention study.Diabetologia2006;49:912-20

[90] Pal S,Binns C,Ellis V.The effect of a fibre supplement compared to a healthy diet on body composition, lipids, glucose, insulin and other metabolic syndrome risk factors in overweight and obese individuals.Br J Nutr2011;105:90-100

[91] Ma Y,Wang J.Single-component versus multicomponent dietary goals for the metabolic syndrome: a randomized trial.Ann Intern Med2015;162:248-57 PMCID:PMC4456033

[92] Tajima R,Enomoto A.No association between fruits or vegetables and non-alcoholic fatty liver disease in middle-aged men and women.Nutrition2019;61:119-24

[93] Bahrami A,Eslamparast T.Legume intake and risk of nonalcoholic fatty liver disease.Indian J Gastroenterol2019;38:55-60

[94] Krawczyk M,Ryterska K.Gut permeability might be improved by dietary fiber in individuals with nonalcoholic fatty liver disease (NAFLD) undergoing weight reduction.Nutrients2018;10:1793 PMCID:PMC6266494

[95] Errazuriz I,Slama M.Randomized controlled trial of a MUFA or fiber-rich diet on hepatic fat in prediabetes.J Clin Endocrinol Metab2017;102:1765-74 PMCID:PMC5443322

[96] Yang Y,Feng N.Increased intake of vegetables, but not fruit, reduces risk for hepatocellular carcinoma: a meta-analysis.Gastroenterology2014;147:1031-42

[97] Perdomo CM,Escalada J.Impact of nutritional changes on nonalcoholic fatty liver disease.Nutrients2019;11:677 PMCID:PMC6470750

[98] Li B,Chan LYY,Tang SCW.A global perspective on the crosstalk between saturated fatty acids and Toll-like receptor 4 in the etiology of inflammation and insulin resistance.Prog Lipid Res2020;77:101020

[99] Machado MV,Jesus L.Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet.Scand J Gastroenterol2008;43:95-102

[100] Mei S,Manley S.Differential roles of unsaturated and saturated fatty acids on autophagy and apoptosis in hepatocytes.J Pharmacol Exp Ther2011;339:487-98 PMCID:PMC3199993

[101] Alnahdi A,Raza H.Augmentation of glucotoxicity, oxidative stress, apoptosis and mitochondrial dysfunction in HepG2 cells by palmitic acid.Nutrients2019;11:1979 PMCID:PMC6770774

[102] Machado MV.Diet, microbiota, obesity, and NAFLD: a dangerous quartet.Int J Mol Sci2016;17:481 PMCID:PMC4848937

[103] Coelho OGL,Alfenas RCG.Dietary fat and gut microbiota: mechanisms involved in obesity control.Crit Rev Food Sci Nutr2019;59:3045-53

[104] Guasch-Ferré M,Martínez-González MA.PREDIMED Study InvestigatorsDietary fat intake and risk of cardiovascular disease and all-cause mortality in a population at high risk of cardiovascular disease.Am J Clin Nutr2015;102:1563-73

[105] Mozaffarian D,Wallace S.Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials.PLoS Med2010;7:e1000252 PMCID:PMC2843598

[106] Guveli H,Ozlu T,Yilmaz Y.Macro- and micronutrients in metabolic (dysfunction) associated fatty liver disease: association between advanced fibrosis and high dietary intake of cholesterol/saturated fatty acids.Eur J Gastroenterol Hepatol2021;

[107] Zhao L,Lin Z,Zhang X.Dietary fats, serum cholesterol and liver cancer risk: a systematic review and meta-analysis of prospective studies.Cancers (Basel)2021;13:1580 PMCID:PMC8037522

[108] Bjermo H,Kullberg J.Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial.Am J Clin Nutr2012;95:1003-12

[109] Rosqvist F,Kullberg J.Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans.Diabetes2014;63:2356-68

[110] Luukkonen PK,Zhou Y.Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars.Diabetes Care2018;41:1732-9 PMCID:PMC7082640

[111] Rosqvist F,Ståhlman M.Overeating saturated fat promotes fatty liver and ceramides compared with polyunsaturated fat: a randomized trial.J Clin Endocrinol Metab2019;104:6207-19 PMCID:PMC6839433

[112] Toshimitsu K,Ohkubo I.Dietary habits and nutrient intake in non-alcoholic steatohepatitis.Nutrition2007;23:46-52

[113] Allard JP,Mohammed S.Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study.J Hepatol2008;48:300-7

[114] Yang J,Martínez-Fernández L.Oxidative stress and non-alcoholic fatty liver disease: effects of omega-3 fatty acid supplementation.Nutrients2019;11:872 PMCID:PMC6521137

[115] Simopoulos A.The importance of the ratio of omega-6/omega-3 essential fatty acids.Biomed Pharmacother2002;56:365-79

[116] Araya J,Videla LA.Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease.Clin Sci (Lond)2004;106:635-43

[117] Pettinelli P,Araya J.Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion.Biochim Biophys Acta2009;1792:1080-6

[118] Sawada N,Iwasaki M.Japan Public Health Center-Based Prospective Study GroupConsumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma.Gastroenterology2012;142:1468-75

[119] Gao M,Guo M.Fish consumption and n-3 polyunsaturated fatty acids, and risk of hepatocellular carcinoma: systematic review and meta-analysis.Cancer Causes Control2015;26:367-76

[120] Luo J,Liu J.Systematic review with meta-analysis: meat consumption and the risk of hepatocellular carcinoma.Aliment Pharmacol Ther2014;39:913-22

[121] Ma Y,Li T.Meat intake and risk of hepatocellular carcinoma in two large US prospective cohorts of women and men.Int J Epidemiol2019;48:1863-71 PMCID:PMC7967811

[122] Hartweg J,Montori V,Neil HA.Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.Cochrane Database Syst Rev2008;:CD003205

[123] Hu Y,Manson JE.Marine omega-3 supplementation and cardiovascular disease: an updated meta-analysis of 13 randomized controlled trials involving 127 477 participants.J Am Heart Assoc2019;8:e013543 PMCID:PMC6806028

[124] Parker HM,Burdon CA,O'Connor HT.Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis.J Hepatol2012;56:944-51

[125] Sanyal AJ,Suzuki A,Chojkier M.EPE-A Study GroupNo significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial.Gastroenterology2014;147:377-84.e1

[126] Lee CH,Yang SJ.Effects of omega-3 polyunsaturated fatty acid supplementation on non-alcoholic fatty liver: a systematic review and meta-analysis.Nutrients2020;12:2769 PMCID:PMC7551292

[127] Bozzetto L,Annuzzi G.Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients.Diabetes Care2012;35:1429-35 PMCID:PMC3379578

[128] Abenavoli L,Milić N,Giuffrè AM.Olive oil antioxidants and non-alcoholic fatty liver disease.Expert Rev Gastroenterol Hepatol2019;13:739-49

[129] Buckland G,Agudo A.Olive oil intake and mortality within the Spanish population (EPIC-Spain).Am J Clin Nutr2012;96:142-9

[130] Sofi F,Cesari F.Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study.Int J Food Sci Nutr2010;61:792-802

[131] Shidfar F,Doaei S,Gholamalizadeh M.The effects of extra virgin olive oil on alanine aminotransferase, aspartate aminotransferase, and ultrasonographic indices of hepatic steatosis in nonalcoholic fatty liver disease patients undergoing low calorie diet.Can J Gastroenterol Hepatol2018;2018:1053710 PMCID:PMC5932499

[132] Rezaei S,Sasani MR.Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: a randomized clinical trial.Nutrition2019;57:154-61

[133] Mazidi M,Mikhailidis DP.Link between plasma trans-fatty acid and fatty liver is moderated by adiposity.Int J Cardiol2018;272:316-22

[134] Neuschwander-Tetri BA,Acharya S.Dietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid pools.Lipids2012;47:941-50 PMCID:PMC3473077

[135] Dowman JK,Reynolds GM.Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle.Am J Pathol2014;184:1550-61 PMCID:PMC4005975

[136] Schnabel L,Allès B.Association between ultraprocessed food consumption and risk of mortality among middle-aged adults in France.JAMA Intern Med2019;179:490-8 PMCID:PMC6450295

[137] Lane MM,Beattie S.Ultraprocessed food and chronic noncommunicable diseases: a systematic review and meta-analysis of 43 observational studies.Obes Rev2021;22:e13146

[138] Mendonça RD,Pimenta AM,Martinez-Gonzalez MA.Ultra-processed food consumption and the incidence of hypertension in a mediterranean cohort: The Seguimiento Universidad de Navarra Project.Am J Hypertens2017;30:358-66

[139] Srour B,Kesse-Guyot E.Ultraprocessed food consumption and risk of type 2 diabetes among participants of the NutriNet-Santé prospective cohort.JAMA Intern Med2020;180:283-91 PMCID:PMC6990737

[140] Fiolet T,Sellem L.Consumption of ultra-processed foods and cancer risk: results from NutriNet-Santé prospective cohort.BMJ2018;360:k322 PMCID:PMC5811844

[141] Yasutake K,Shima Y.Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.Scand J Gastroenterol2009;44:471-7

[142] Simoni-Nieves A,Chávez-Rodríguez L.The consumption of cholesterol-enriched diets conditions the development of a subtype of HCC with high aggressiveness and poor prognosis.Cancers (Basel)2021;13:1721 PMCID:PMC8038696

[143] Machado MV.Nonalcoholic fatty liver disease in lean subjects: is it all metabolic-associated fatty liver disease?.Hepatoma Res2020;6:84

[144] Ioannou GN.The role of cholesterol in the pathogenesis of NASH.Trends Endocrinol Metab2016;27:84-95

[145] Bortolotti M,Debard C.High protein intake reduces intrahepatocellular lipid deposition in humans.Am J Clin Nutr2009;90:1002-10

[146] Markova M,Hornemann S.Isocaloric diets high in animal or plant protein reduce liver fat and inflammation in individuals with type 2 diabetes.Gastroenterology2017;152:571-85.e8

[147] Drummen M,Vreugdenhil ACE.Long-term effects of increased protein intake after weight loss on intrahepatic lipid content and implications for insulin sensitivity: a PREVIEW study.Am J Physiol Endocrinol Metab2018;315:E885-91

[148] Arciero PJ,Pressman R.Moderate protein intake improves total and regional body composition and insulin sensitivity in overweight adults.Metabolism2008;57:757-65

[149] Wycherley TP,Clifton PM,Brinkworth GD.Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials.Am J Clin Nutr2012;96:1281-98

[150] Haghighat N,Bagheri R.The effect of 12 weeks of euenergetic high-protein diet in regulating appetite and body composition of women with normal-weight obesity: a randomised controlled trial.Br J Nutr2020;124:1044-51

[151] Peng LN,Lee HF,Chen LK.Protein-enriched diet improved muscle endurance and marginally reduced intramuscular adiposity: results from a randomized controlled trial among middle-aged and older adults.Arch Gerontol Geriatr2021;96:104436

[152] Blachier F,Portune KJ.High-protein diets for weight management: Interactions with the intestinal microbiota and consequences for gut health. A position paper by the my new gut study group.Clin Nutr2019;38:1012-22

[153] Ko GJ,Kalantar-Zadeh K.The effects of high-protein diets on kidney health and longevity.J Am Soc Nephrol2020;31:1667-79 PMCID:PMC7460905

[154] Kim E,Blachier F.Review of the association between meat consumption and risk of colorectal cancer.Nutr Res2013;33:983-94

[155] Díaz-Rúa R,Palou A,Oliver P.Long-term intake of a high-protein diet increases liver triacylglycerol deposition pathways and hepatic signs of injury in rats.J Nutr Biochem2017;46:39-48

[156] Shang X,Hodge AM.Dietary protein intake and risk of type 2 diabetes: results from the Melbourne Collaborative Cohort Study and a meta-analysis of prospective studies.Am J Clin Nutr2016;104:1352-65

[157] Shang X,Hodge A.Dietary protein from different food sources, incident metabolic syndrome and changes in its components: an 11-year longitudinal study in healthy community-dwelling adults.Clin Nutr2017;36:1540-8

[158] Tharrey M,Mashchak A,Delattre M.Patterns of plant and animal protein intake are strongly associated with cardiovascular mortality: the Adventist Health Study-2 cohort.Int J Epidemiol2018;47:1603-12 PMCID:PMC6658814

[159] Navas-Carretero S,Livingstone KM.Higher vegetable protein consumption, assessed by an isoenergetic macronutrient exchange model, is associated with a lower presence of overweight and obesity in the web-based Food4me European study.Int J Food Sci Nutr2019;70:240-53

[160] Naghshi S,Willett WC.Dietary intake of total, animal, and plant proteins and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of prospective cohort studies.BMJ2020;370:m2412 PMCID:PMC7374797

[161] Mariotti F.Animal and plant protein sources and cardiometabolic health.Adv Nutr2019;10:S351-66 PMCID:PMC6855969

[162] Sobiecki JG,Bradbury KE.High compliance with dietary recommendations in a cohort of meat eaters, fish eaters, vegetarians, and vegans: results from the European Prospective Investigation into Cancer and Nutrition-Oxford study.Nutr Res2016;36:464-77 PMCID:PMC4844163

[163] Etemadi A,Ward MH.Mortality from different causes associated with meat, heme iron, nitrates, and nitrites in the NIH-AARP Diet and Health Study: population based cohort study.BMJ2017;357:j1957 PMCID:PMC5423547

[164] Freedman ND,McGlynn KA.Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohort.J Natl Cancer Inst2010;102:1354-65 PMCID:PMC2935477

[165] Shi L,Li Y.The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu.Biomed Environ Sci2012;25:383-91

[166] Zelber-Sagi S,Fliss Isakov N.High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance.J Hepatol2018;68:1239-46

[167] Zheng W.Well-done meat intake, heterocyclic amine exposure, and cancer risk.Nutr Cancer2009;61:437-46 PMCID:PMC2769029

[168] Uribarri J,Goodman S.Advanced glycation end products in foods and a practical guide to their reduction in the diet.J Am Diet Assoc2010;110:911-16.e12 PMCID:PMC3704564

[169] Ivancovsky-Wajcman D,Fliss Isakov N.Serum soluble receptor for AGE (sRAGE) levels are associated with unhealthy lifestyle and nonalcoholic fatty liver disease.Clin Transl Gastroenterol2019;10:1-10 PMCID:PMC6602762

[170] Kani AH,Esmaillzadeh A,Azadbakht L.Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: a parallel randomized trial.Nutrition2014;30:814-21

[171] Xiong P.Soy diet for nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials.Medicine (Baltimore)2021;100:e25817 PMCID:PMC8183754

[172] Kou T,Cai J.Effect of soybean protein on blood pressure in postmenopausal women: a meta-analysis of randomized controlled trials.Food Funct2017;8:2663-71

[173] Rizzo NS,Sabate J.Nutrient profiles of vegetarian and nonvegetarian dietary patterns.J Acad Nutr Diet2013;113:1610-9 PMCID:PMC4081456

[174] Dixon JB,O'Brien PE.Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.Gastroenterology2001;121:91-100

[175] Kwon HK,Conjeevaram HS.Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease.Liver Int2014;34:129-35

[176] Dunn W,Brunt EM.Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).J Hepatol2012;57:384-91 PMCID:PMC3399018

[177] Mitchell T,de Boer B.Type and pattern of alcohol consumption is associated with liver fibrosis in patients with non-alcoholic fatty liver disease.Am J Gastroenterol2018;113:1484-93

[178] Yamada K,Seike T.Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease.PLoS One2018;13:e0191026 PMCID:PMC5771612

[179] Moriya A,Ohguchi S.Roles of alcohol consumption in fatty liver: a longitudinal study.J Hepatol2015;62:921-7

[180] Hagström H,Ekstedt M.Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease.Scand J Gastroenterol2017;52:159-65

[181] Hashimoto Y,Kojima T.Modest alcohol consumption reduces the incidence of fatty liver in men: a population-based large-scale cohort study.J Gastroenterol Hepatol2015;30:546-52

[182] Åberg F.Drinking and obesity: alcoholic liver disease/nonalcoholic fatty liver disease interactions.Semin Liver Dis2020;40:154-62

[183] Long MT,Hoffmann U,Naimi TS.Alcohol use is associated with hepatic steatosis among persons with presumed nonalcoholic fatty liver disease.Clin Gastroenterol Hepatol2020;18:1831-1841.e5 PMCID:PMC7569606

[184] Ekstedt M,Holmqvist M.Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.Scand J Gastroenterol2009;44:366-74

[185] Åberg F,Puukka P.Binge drinking and the risk of liver events: a population-based cohort study.Liver Int2017;37:1373-81

[186] Kashiwagi K,Shiba S.Moderate alcohol consumption is not associated with subclinical cardiovascular damage but with hepatic fibrosis in non-alcoholic fatty liver disease.Alcohol2020;89:1-7

[187] Blomdahl J,Ekstedt M.Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus.Metabolism2021;115:154439

[188] Ajmera V,Wilson LA.Nonalcoholic Steatohepatitis Clinical Research NetworkAmong patients with nonalcoholic fatty liver disease, modest alcohol use is associated with less improvement in histologic steatosis and steatohepatitis.Clin Gastroenterol Hepatol2018;16:1511-20.e5 PMCID:PMC6098737

[189] Chang Y,Kim Y.Nonheavy drinking and worsening of noninvasive fibrosis markers in nonalcoholic fatty liver disease: a cohort study.Hepatology2019;69:64-75

[190] Chang Y,Kim Y.Low levels of alcohol consumption, obesity, and development of fatty liver with and without evidence of advanced fibrosis.Hepatology2020;71:861-73

[191] Åberg F,Puukka P,Jula A.Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population.Hepatology2018;67:2141-9

[192] Ruhl CE.Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population.Clin Gastroenterol Hepatol2005;3:1260-8

[193] Alatalo PI,Hietala JP,Bloigu R.Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index.Am J Clin Nutr2008;88:1097-103

[194] Loomba R,Barrett-Connor E.Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study.Aliment Pharmacol Ther2009;30:1137-49 PMCID:PMC3220929

[195] Hart CL,Batty GD,Davey Smith G.Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies.BMJ2010;340:c1240 PMCID:PMC2837144

[196] Liu B,Reeves G.Million Women Study CollaboratorsBody mass index and risk of liver cirrhosis in middle aged UK women: prospective study.BMJ2010;340:c912 PMCID:PMC2837146

[197] Loomba R,Su J.Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.Am J Epidemiol2013;177:333-42 PMCID:PMC3626057

[198] Ascha MS,Lopez R,Feldstein AF.The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.Hepatology2010;51:1972-8

[199] Hajifathalian K,McCullough AJ.Effect of alcohol consumption on survival in nonalcoholic fatty liver disease: a national prospective cohort study.Hepatology2019;70:511-21 PMCID:PMC6380949

[200] GBD 2016 Alcohol CollaboratorsAlcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.Lancet2018;392:1015-35 PMCID:PMC6148333

[201] Wijarnpreecha K,Ungprasert P.Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis.Eur J Gastroenterol Hepatol2017;29:e8-e12

[202] Hayat U,Okut H,Tasleem S.The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies.Ann Hepatol2021;20:100254

[203] Chen YP,Hu YB,Zheng MH.A systematic review and a dose-response meta-analysis of coffee dose and nonalcoholic fatty liver disease.Clin Nutr2019;38:2552-7

[204] Zelber-Sagi S,Webb M.Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population.Transl Res2015;165:428-36

[205] Sewter R,Patterson A.Coffee consumption and the progression of NAFLD: a systematic review.Nutrients2021;13:2381 PMCID:PMC8308484

[206] Crozier TW,Lean ME.Espresso coffees, caffeine and chlorogenic acid intake: potential health implications.Food Funct2012;3:30-3

[207] Anty R,Iannelli A.Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery.J Hepatol2012;57:1090-6

[208] Xiao Q,Graubard BI.Inverse associations of total and decaffeinated coffee with liver enzyme levels in National Health and Nutrition Examination Survey 1999-2010.Hepatology2014;60:2091-8 PMCID:PMC4245376

[209] Kennedy OJ,Buchanan R,Hayes PC.Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis.BMJ Open2017;7:e013739 PMCID:PMC5730000

[210] Zelber-Sagi S.Dietary treatment for NAFLD: new clinical and epidemiological evidence and updated recommendations.Semin Liver Dis2021;41:248-62

[211] Anania C,Olivero F,Chiesa C.Mediterranean diet and nonalcoholic fatty liver disease.World J Gastroenterol2018;24:2083-94 PMCID:PMC5960814

[212] Eslamparast T,Raman M.Dietary composition independent of weight loss in the management of non-alcoholic fatty liver disease.Nutrients2017;9:800 PMCID:PMC5579594

[213] Kontogianni MD,Margariti A.Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease.Clin Nutr2014;33:678-83

[214] Aller R,de la Fuente B.Mediterranean diet is associated with liver histology in patients with non alcoholic fatty liver disease.Nutr Hosp2015;32:2518-24

[215] Trovato FM,Brischetto D,Catalano D.Neglected features of lifestyle: their relevance in non-alcoholic fatty liver disease.World J Hepatol2016;8:1459-65 PMCID:PMC5124717

[216] Corte C, Mosca A, Vania A, Alterio A, Iasevoli S, Nobili V. Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: the results of an Italian Study.Nutrition2017;39-40:8-14

[217] Turati F,Polesel J.Mediterranean diet and hepatocellular carcinoma.J Hepatol2014;60:606-11

[218] Ryan MC,Thodis T.The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease.J Hepatol2013;59:138-43

[219] Trovato FM,Martines GF,Trovato GM.Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions.Clin Nutr2015;34:86-8

[220] Cueto-Galán R,Valdivielso P.los investigadores del Estudio PREDIMEDChanges in fatty liver index after consuming a Mediterranean diet: 6-year follow-up of the PREDIMED-Malaga trial.Med Clin (Barc)2017;148:435-43

[221] Abenavoli L,Milic N.Effect of mediterranean diet and antioxidant formulation in non-alcoholic fatty liver disease: a randomized study.Nutrients2017;9:870 PMCID:PMC5579663

[222] Katsagoni CN,Ioannidou P.Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.Br J Nutr2018;120:164-75

[223] Kaliora AC,Kalafati IP,Kokkinos A.The effectiveness of mediterranean diet in nonalcoholic fatty liver disease clinical course: an intervention study.J Med Food2019;22:729-40

[224] Moosavian SP,Paknahad Z.The effect of a Mediterranean diet on metabolic parameters in patients with non-alcoholic fatty liver disease: a systematic review of randomized controlled trials.Clin Nutr ESPEN2020;35:40-6

[225] Asbaghi O,Ashtary-Larky D.Effects of the Mediterranean diet on cardiovascular risk factors in non-alcoholic fatty liver disease patients: a systematic review and meta-analysis.Clin Nutr ESPEN2020;37:148-56

[226] Akhlaghi M,Riasatian M.Mediterranean diet for patients with non-alcoholic fatty liver disease, a systematic review and meta-analysis of observational and clinical investigations.J Diabetes Metab Disord2020;19:575-84 PMCID:PMC7271299

[227] Kawaguchi T,Kawaguchi A.Effects of Mediterranean diet in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression analysis of randomized controlled trials.Semin Liver Dis2021;41:225-34

[228] Rees K,Martin N.Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease: a Cochrane review.Glob Heart2020;15:56 PMCID:PMC7427685

[229] Berná G.The role of nutrition in non-alcoholic fatty liver disease: pathophysiology and management.Liver Int2020;40 Suppl 1:102-8

[230] Hekmatdoost A,Meibodi M,Eslamparast T.Adherence to the dietary approaches to stop hypertension (DASH) and risk of nonalcoholic fatty liver disease.Int J Food Sci Nutr2016;67:1024-9

[231] Xiao ML,Li YH.Adherence to the dietary approaches to stop hypertension (DASH) diet is associated with lower presence of non-alcoholic fatty liver disease in middle-aged and elderly adults.Public Health Nutr2020;23:674-82

[232] Zade M, Telkabadi MH, Bahmani F, Salehi B, Farshbaf S, Asemi Z. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial.Liver Int2016;36:563-71

[233] Kang J,Faigenbaum AD.Effect of time-restricted feeding on anthropometric, metabolic, and fitness parameters: a systematic review.J Am Coll Nutr2021;:1-16

[234] Yin C,Xiang Y.Effect of intermittent fasting on non-alcoholic fatty liver disease: systematic review and meta-analysis.Front Nutr2021;8:709683 PMCID:PMC8310935

[235] Holmer M,Petersson S.Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial.JHEP Rep2021;3:100256 PMCID:PMC8059083

[236] Younossi ZM,Lim JK.AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: expert review.Gastroenterology2021;160:912-8

[237] Chalasani N,Lavine JE.The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases.Hepatology2018;67:328-57

[238] European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Diabetes (EASD)EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.Diabetologia2016;59:1121-40

[239] Glen J,Day C.Guideline Development GroupNon-alcoholic fatty liver disease (NAFLD): summary of NICE guidance.BMJ2016;354:i4428

[240] LaBrecque DR,Anania F.Review Team, World Gastroenterology OrganisationWorld Gastroenterology Organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.J Clin Gastroenterol2014;48:467-73

[241] Zelber-Sagi S,Dror-Lavi G.Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients.World J Gastroenterol2017;23:1881-90 PMCID:PMC5352930

[242] Machado MV.Aerobic exercise in the management of metabolic dysfunction associated fatty liver disease.Diabetes Metab Syndr Obes2021;14:3627-45 PMCID:PMC8364841

[243] De Chiara F,Ramón Azcón J.High protein diet and metabolic plasticity in non-alcoholic fatty liver disease: myths and truths.Nutrients2019;11:2985 PMCID:PMC6950466

[244] 2015-2020 Dietary Guidelines For Americans. 2020; 8th ed. Available from: https://health.gov/sites/default/files/2019-09/2015-2020_Dietary_Guidelines.pdf. [Last accessed on 25 Oct 2021]